Clinical Trial Update: An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

View source ↗

Summary

An observational real-world study evaluated outcomes in patients treated with tolvaptan for hyponatremia due to SIADH, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Europe Ltd | Conditions: Hyponatremia, Syndrome of Inappropriate ADH (SIADH) Secretion | Status: COMPLETED | Results posted: 2018-02-05